Asia-Pacific Journal of Clinical Oncology

Published by: Wiley Blackwell  

People

  1. Motzer
    Motzer
  2. Postow
    Postow
  3. Bajorin
    Bajorin
  4. Yaeger
    Yaeger
  5. Abida
    Abida
  6. Abou-Alfa
    Abou-Alfa
  7. Costas Muniz
    Costas Muniz
  8. D'Angelo
    D'Angelo
  9. Feldman
    Feldman
  10. Gany
    Gany

Groups

  1. Department of Medicine (52)
  2. Solid Tumor Oncology Division (52)
  3. Melanoma and Immunotherapeutics Service (22)
  4. GSK Faculty (18)
  5. Genitourinary Oncology Service (15)
  6. Melanoma Disease Management Team (9)
  7. Psychiatry and Behavioral Sciences, Department of (6)
  8. Gastrointestinal Oncology Service (5)
  9. Thoracic Oncology (5)
  10. Consultants (4)
Search Within
Formats
  1. Meeting Abstract (69)
  2. Journal Article (3)
  3. Correspondence (2)
Groups
  1. Department of Medicine (52)
  2. Solid Tumor Oncology Division (52)
  3. Melanoma and Immunotherapeutics Service (22)
  4. GSK Faculty (18)
  5. Genitourinary Oncology Service (15)
  6. Melanoma Disease Management Team (9)

More Groups

People
  1. Jedd Wolchok (18)
  2. Robert Motzer (7)
  3. Naiyer Rizvi (6)
  4. Michael Postow (5)
  5. Dean Bajorin (4)
  6. Rona Yaeger (3)

More People

Years
  1. 2023 (1)
  2. 2022 (9)
  3. 2021 (7)
  4. 2019 (6)
  5. 2018 (3)
  6. 2017 (10)

More Years

Publishers
  1. Wiley Blackwell (74)

Results (74)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Checkmate 067: A phase III randomized double-blind study of nivolumab (NIVO) monotherapy or NIVO combined with pilimumab (IPI) versus IPI monotherapy in previously untreated patients (PTS) with advanced melanoma (MEL)
    Meeting Abstract

    Wolchok, J. D.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J. J.; Cowey, C. L.; Lao, C. D.; Schadendorf, D.; Ferrucci, P. F.; Smylie, M.; more...
    Asia-Pacific Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A pooled analysis of 655 patients with advanced melanoma enrolled in keynote-001: Long-term efficacy of pembrolizumab (MK-3475)
    Meeting Abstract

    Daud, A.; Joshua, A. M.; Ribas, A.; Robert, C.; Hodi, F. S.; Wolchok, J.; Hwu, W. J.; Weber, J. S.; Gangadhar, T. C.; Joseph, R.; more...
    Asia-Pacific Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Diagnostic value of rectal bleeding in predicting CRC in developing country - Pilot study
    Meeting Abstract

    Alatise, O.; Kingham, T. P.
    Asia-Pacific Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-programmed death-1) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL)
    Meeting Abstract

    Sznol, M.; Kluger, H.; Callahan, M. K.; Postow, M. A.; Gordon, R.; Seal, N. H.; Rizvi, N. A.; Lesokhin, A. M.; Atkins, M. B.; Kirkwood, J. M.; more...
    Asia-Pacific Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Barriers and access to cancer care: Where does ethics fit?
    Meeting Abstract

    McCabe, M.
    Asia-Pacific Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Cancer survivorship: The future is now
    Meeting Abstract

    McCabe, M.
    Asia-Pacific Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Long-term survival of ipilimumab-naive patients with advanced melanoma (MEL) treated with nivolumab (anti-programmed peath-1; Anti-PD-1; Bms-936558; Ono-4538) in a phase I trial
    Meeting Abstract

    Hodi, S.; Sznol, M.; Kluger, H. M.; McDermott, D. F.; Carvajal, R. D.; Lawrence, D. P.; Topalian, S. L.; Atkins, M. B.; Powderly, J. D.; Sharfman, W. H.; more...
    Asia-Pacific Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Ipilimumab versus placebo after complete resection of stage III melanoma: Efficacy and safety results from the EORTC 18071 phase III trial
    Meeting Abstract

    Eggermont, A. M.; Chiarion-Sileni, V.; Grob, J. J.; Dummer, R.; Wolchok, J. D.; Schmidt, H.; Hamid, O.; Robert, C.; Ascierto, P. A.; Richards, J. M.; more...
    Asia-Pacific Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Nivolumab in patients with advanced non-small-cell lung cancer (NSCLC): Survival and clinical activity by subgroup analysis
    Meeting Abstract

    Brahmer, J. R.; Horn, L.; Gandhi, L.; Spigel, D. R.; Antonia, S. J.; Rizvi, N. A.; Powderly, J. D.; Heist, R. S.; Carvajal, R. D.; Jackman, D. M.; more...
    Asia-Pacific Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Nivolumab and ipilimumab in first-line non-small-cell lung carcinoma (NSCLC): Interim phase I results
    Meeting Abstract

    Antonia, S. J.; Gettinger, S.; Chow, L. Q.; Juergens, R.; Borghaei, H.; Shen, Y.; Harbison, C.; Chen, A. C.; Ready, N. E.; Rizvi, N. A.
    Asia-Pacific Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save

    • Asia-Pacific Journal of Clinical Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    Asia-Pacific Journal of Clinical Oncology 1743-7555 Wiley Blackwell
    Asia-Pacific Journal of Clinical Oncology 17437555 Unknown
    Asia-Pacific Journal of Clinical Oncology 17437555 The Authors Journal Compilation © 2008 Blackwell Publishing Ltd
    Asia-Pacific Journal of Clinical Oncology 1743-7555 Wiley Blackwell
    Asia-Pacific Journal of Clinical Oncology 17437555 John Wiley & Sons Australia, Ltd
    Asia-Pacific Journal of Clinical Oncology 1743-7555 Wiley Blackwell